AAIPharma appoints new COO
This article was originally published in Scrip
The US-based company AAIPharma has appointed Scott Neilsonchief operating officer. Mr Neilson, who has worked with MDS Pharma Services, LabCorp, Covance and SmithKline Beecham, will be responsible for AAIPharma's global drug development services operations. The company provides product development and support services to the pharmaceutical, biotech and medical device industries.
You may also be interested in...
In addition to agreeing to emergency use of the Oxford University/Astra Zeneca and Sinovac vaccines, Brazil's medicines regulator has also published good manufacturing practices certificates for Pfizer and Janssen vaccine. It has questions about the Sputnik V authorization request.
A Dutch parallel registration and reimbursement pilot has brought benefits including more participation from healthcare professionals, and also forces company divisions to be less streamlined.
The UK’s withdrawal from the EU could upset the Unitary Patent Court project.